NeuroSense Therapeutics L... (NRSNW)
0.15
-0.05 (-25.00%)
At close: Mar 03, 2025, 11:53 AM
0.21
40.24%
Pre-market: Mar 03, 2025, 11:54 AM EST
NeuroSense Therapeutics Ltd. Revenue
NeuroSense Therapeutics Ltd. reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending September 30, 2024, NeuroSense Therapeutics Ltd. generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
18
Market Cap
3.17M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|---|---|
Dec 31, 2023 | 0 | n/a |
Dec 31, 2022 | 0 | n/a |
Dec 31, 2021 | 0 | n/a |
Dec 31, 2020 | 0 | n/a |